首页 | 本学科首页   官方微博 | 高级检索  
     

放化疗配合中医辩证治疗脑转移瘤临床观察
引用本文:金达芳,陆永奎. 放化疗配合中医辩证治疗脑转移瘤临床观察[J]. 中国中西医结合杂志, 1999, 19(7): 392-394
作者姓名:金达芳  陆永奎
作者单位:广西权衡利弊大学附属肿瘤医院
摘    要:
目的:观察放化疗配合中医辩证治疗脑转移瘤临床疗效。方法:67例患者随机分为化疗配合中药组(观察Ⅰ),放疗配合中药组(观察Ⅱ)与单纯化疗组(对照Ⅰ),单纯疗组(对照Ⅱ),对4组疗效作比较观察。结果:观察Ⅰ、Ⅱ组患者近期有效率(完全缓解加部分缓解)、生存质量、1~4年自下而上率及中位生存时间、部分免疫功能指标明显高于对照Ⅰ、Ⅱ组(P〈0.05)。结论:放化疗配合中医辩证治疗脑转移瘤,具有抑制肿瘤生长,

关 键 词:脑转移瘤  化疗  放疗  生存期  生存质量  辩证论治

Clinical observation on radio- or chemotherapy plus Traditional Chinese medicine in treating brain metastatic tumor]
D Quan,Y Lu,Z Li. Clinical observation on radio- or chemotherapy plus Traditional Chinese medicine in treating brain metastatic tumor][J]. Chinese journal of integrated traditional and Western medicine, 1999, 19(7): 392-394
Authors:D Quan  Y Lu  Z Li
Affiliation:Affiliated Tumor Hospital of Guangxi Medical University, Nanning (530021).
Abstract:
OBJECTIVE: To observe the clinical efficacy of radio- or chemotherapy plus traditional Chinese medicine (TCM) by Syndrome Differentiation in treating brain metastatic tumor. METHODS: Forty-one patients were randomized into four groups: Group A treated with chemotherapy plus TCM, Group B with radiotherapy plus TCM, Group C with chemotherapy alone and Group D with radiotherapy alone. The efficacies of the four groups were compared. RESULTS: The short-term response rate, living quality, 1-, 2-, 3- and 4-year survival rate, median survival period and immunity of the Group A and B were significantly higher than those of the Group C and D (P < 0.05). CONCLUSION: Radio- or chemotherapy plus TCM by Syndrome Differentiation has the effect of tumor growth inhibition, survival period extension and living quality enhancement in treating brain metastases.
Keywords:
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号